Concepedia

Sophie Bellanger

SB

16

Publications

759

Citations

15

H-Index

2001

Active since

Affiliations

Agency for Science, Technology and Research(Current)

Institute of Medical Biology

Procter & Gamble (United States)

Centre National de la Recherche Scientifique

National Skin Centre

Sophie Bellanger is an author at Agency for Science, Technology and Research specializing in cell biology, medicine, and molecular biology.

ORCID

Top concepts

Publications per year

2001–2023

16

Publications

16

HPV16 E2 Is an Immediate Early Marker of Viral Infection, Preceding E7 Expression in Precursor Structures of Cervical Carcinoma

Yuezhen Xue, Sophie Bellanger, Wenying Zhang et al. · Cancer Research · 2010 · 96 citations · Full text

, , +19

High-Risk But Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability

Sophie Bellanger, Stéphanie Blachon, Francisca Méchali et al. · Cell Cycle · 2005 · 79 citations

Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism

Deborah Lai, Chye Ling Tan, Jayantha Gunaratne et al. · PLoS ONE · 2013 · 77 citations · Full text

, , +20

Nucleo-cytoplasmic Shuttling of High Risk Human Papillomavirus E2 Proteins Induces Apoptosis

Stéphanie Blachon, Sophie Bellanger, Caroline Demeret et al. · Journal of Biological Chemistry · 2005 · 74 citations · Full text

Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2

Sophie Bellanger, Armand de Gramont, Joëlle Sobczak‐Thépot · Oncogene · 2007 · 55 citations · Full text

, , +11

Rows per page

1–5 of 16